Literature DB >> 6393495

[Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study].

J L Madsen, S Hvidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6393495

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN： 0041-5782


× No keyword cloud information.
  4 in total

1.  Subjective and objective assessment of enalapril in primary Raynaud's phenomenon.

Authors:  V F Challenor; D G Waller; R A Hayward; M J Griffin; O S Roath
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 2.  Angiotensin converting enzyme inhibitors in Raynaud's phenomenon.

Authors:  V F Challenor
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 3.  Oral vasodilators for primary Raynaud's phenomenon.

Authors:  Marlene Stewart; Joanne R Morling
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

4.  Vasodilators for primary Raynaud's phenomenon.

Authors:  Kevin Yc Su; Meghna Sharma; Hyunjun Jonathan Kim; Elizabeth Kaganov; Ian Hughes; Mohamed Hashim Abdeen; Jennifer Hwee Kwoon Ng
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.